No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BNGO240517C2000
- 0.04
- 0.000.00%
15min DelayTrading Apr 4 13:56 ET
0.00High0.00Low
0.00Open0.04Pre Close0 Volume1.02K Open Interest2.00Strike Price0.00Turnover377.87%IV106.12%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.04Time Value100Contract SizeAmericanOptions Type0.1694Delta0.4496Gamma24.74Leverage Ratio-0.0083Theta0.0000Rho4.19Eff Leverage0.0004Vega
Intraday
- 5D
- 1D
News
Bionano Stock Climbs 7% in Wake of Q1 Report, Software Upgrades
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
Q1 2024 Bionano Genomics Inc Earnings Call
Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Bionano Announces Series of Major Advancements to Its Suite of Computational Tools for Comprehensive Cancer Analysis
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These ad
Comments
$Bionano Genomics(BNGO.US$ Scotiabank BUY rating $6.00 Target Price
$Bionano Genomics(BNGO.US$ Bionano Genomics Q1 2024 GAAP EPS $(0.60) Beats $(0.65) Estimate, Sales $8.769M Beat $8.492M Estimate
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
$Bionano Genomics(BNGO.US$ $0.08 per shares now 🤣🤣🤣🤣 used to he $12 at lrak LMFAO
$Bionano Genomics(BNGO.US$ Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis That Combines Ogm and Artificial Intelligence
$Bionano Genomics(BNGO.US$ b i n go b i ngo b i ngo and bingo crashed to 1 cent !
Read more